Northern Trust’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.68M | Sell |
928,240
-2,080
| -0.2% | -$10.5K | ﹤0.01% | 2492 |
|
|
2025
Q1 | $6.03M | Sell |
930,320
-134
| -0% | -$868 | ﹤0.01% | 2323 |
|
|
2024
Q4 | $6.83M | Buy |
930,454
+51,530
| +6% | +$378K | ﹤0.01% | 2337 |
|
|
2024
Q3 | $6.58M | Buy |
878,924
+45,433
| +5% | +$340K | ﹤0.01% | 2319 |
|
|
2024
Q2 | $7.42M | Sell |
833,491
-25,100
| -3% | -$223K | ﹤0.01% | 2167 |
|
|
2024
Q1 | $8.7M | Sell |
858,591
-78,713
| -8% | -$797K | ﹤0.01% | 2126 |
|
|
2023
Q4 | $9.43M | Sell |
937,304
-61,249
| -6% | -$616K | ﹤0.01% | 2119 |
|
|
2023
Q3 | $9.36M | Buy |
998,553
+21,808
| +2% | +$204K | ﹤0.01% | 2056 |
|
|
2023
Q2 | $24M | Buy |
976,745
+110,365
| +13% | +$2.71M | ﹤0.01% | 1465 |
|
|
2023
Q1 | $20.2M | Buy |
866,380
+87,681
| +11% | +$2.04M | ﹤0.01% | 1541 |
|
|
2022
Q4 | $19.7M | Sell |
778,699
-51,965
| -6% | -$1.32M | ﹤0.01% | 1531 |
|
|
2022
Q3 | $16M | Sell |
830,664
-23,739
| -3% | -$458K | ﹤0.01% | 1649 |
|
|
2022
Q2 | $21.8M | Buy |
854,403
+243,076
| +40% | +$6.19M | ﹤0.01% | 1465 |
|
|
2022
Q1 | $15.7M | Sell |
611,327
-8,180
| -1% | -$210K | ﹤0.01% | 1843 |
|
|
2021
Q4 | $25.9M | Sell |
619,507
-3,142
| -0.5% | -$132K | ﹤0.01% | 1588 |
|
|
2021
Q3 | $27.1M | Sell |
622,649
-28,611
| -4% | -$1.25M | ﹤0.01% | 1568 |
|
|
2021
Q2 | $30.8M | Buy |
651,260
+46,639
| +8% | +$2.21M | 0.01% | 1570 |
|
|
2021
Q1 | $31M | Sell |
604,621
-32,392
| -5% | -$1.66M | 0.01% | 1508 |
|
|
2020
Q4 | $17.1M | Sell |
637,013
-17,808
| -3% | -$477K | ﹤0.01% | 1905 |
|
|
2020
Q3 | $22.5M | Buy |
654,821
+164,032
| +33% | +$5.63M | ﹤0.01% | 1533 |
|
|
2020
Q2 | $20.1M | Buy |
490,789
+381,561
| +349% | +$15.6M | ﹤0.01% | 1620 |
|
|
2020
Q1 | $3.74M | Buy |
109,228
+3,476
| +3% | +$119K | ﹤0.01% | 2471 |
|
|
2019
Q4 | $1.33M | Buy |
+105,752
| New | +$1.33M | ﹤0.01% | 3300 |
|